Salute e Benessere
The Oxford-Harrington Rare Disease Centre (OHC) Announces Inaugural 2024 Rare Disease Scholar Award Recipients
The OHC brings together world-leading research, expertise in therapeutics development and new financial models to advance solutions to critical challenges in rare diseases.
Each Scholar will receive £100,000 (UK) / $100,000 (US and Canada ), personalised therapeutics development support from industry experts to help bring new therapeutics to market, and the opportunity to receive acceleration and investment funds of up to £1,000,000 based on project milestones.
–
University of North Carolina at Chapel Hill , NC, USA
– Institute of Cancer Research,
London, UK
–
Duke University , Durham, NC , USA
–
University of Pennsylvania , Philadelphia, PA , USA
–
Tufts University School of Medicine , Medford, MA , USA
–
University of Toronto , Toronto, Canada
–
New York University , New York City , NY, USA
– University of Oxford ,
Oxford, UK
– Boston Children's Hospital,
Boston, MA , USA
– University College London,
London, UK
For those interested in submitting a proposal for the Oxford-Harrington Rare Disease Scholar Award, . For more information, visit: OxfordHarrington.org/funding/overview
View original content: https://www.prnewswire.co.uk/news-releases/the-oxford-harrington-rare-disease-centre-ohc-announces-inaugural-2024-rare-disease-scholar-award-recipients-302285282.html